Hologic is a U.S.-based medical technology company focused on women’s health, combining diagnostics, breast imaging, gynecologic surgery and bone health products. It develops, manufactures, sells and services premium systems and consumables used for early detection, diagnosis and treatment across hospitals, laboratories and physician practices.
20,1 %
51,6 %
13,8 %
+1,7 %
3.75
3.06
| % | |
|---|---|
| Diagnostics | 40% Molecular diagnostic instruments, assays and related consumables used by clinical laboratories and healthcare providers. |
| Breast Health | 35% Breast imaging, biopsy, localization and related products used for screening and diagnosis. |
| GYN Surgical | 15% Gynecologic surgical systems and disposable products used in minimally invasive procedures. |
| Skeletal Health | 10% Bone density and orthopedic imaging systems, including DXA and mini C-arm products. |
Hologic sells to clinical laboratories, hospitals, healthcare systems and physicians, with distinct buying centers...
Buy diagnostic instruments, assays and consumables for infectious disease and other testing workflows.
Buy breast imaging, biopsy and surgical systems through capital and purchasing contracts.
Buy GYN surgical and bone health products for office-based and ambulatory procedures.
Managed care organizations, IDNs and government facilities negotiate access and pricing.
Sell and service products in markets where Hologic uses indirect channels.
Hologic is headquartered in the United States and generates sales through direct teams and distributors across North...
Hologic’s strategy centers on women’s health across the care continuum, using clinical evidence, FDA labeling and...
Clinical evidence and product breadth help sustain pricing and customer loyalty in competitive markets.
Direct customer relationships improve adoption, service quality and recurring revenue from the installed base.
Acquisitions, divestiture-like product exits and the pending take-private transaction affect long-term flexibility.
Hologic faces intense competition from larger medtech and diagnostics companies, which can pressure pricing,...
Larger rivals may offer broader portfolios, stronger brands or lower prices, reducing Hologic's pricing power.
The Blackstone/TPG transaction depends on stockholder, regulatory and other closing conditions.
Connected medical products and data systems can be targeted by ransomware, phishing and other attacks.
A limited number of customers account for a meaningful share of Diagnostics revenue.
Loss or underperformance of distributors can reduce sales and service reach in serviced territories.
: 28.4.2026